{"DataElement":{"publicId":"3776032","version":"1","preferredName":"Charlson Comorbidity Index Chart Review Version Has Solid Tumor Name","preferredDefinition":"Text field for the name of a solid tumor(s) an individual has or had, determined by reviewing information from the medical record.","longName":"CCI_ SOLIDTUMOR_NM","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3775785","version":"1","preferredName":"Charlson Comorbidity Index Chart Review Version Has Solid Tumor","preferredDefinition":"A method of predicting mortality by weighting comorbid conditions calculated by reviewing an individual's chart._A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","longName":"3775629v1.0:3775783v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3775629","version":"1","preferredName":"Charlson Comorbidity Index Chart Review Version","preferredDefinition":"A method of predicting mortality by weighting comorbid conditions calculated by reviewing an individual's chart.","longName":"C106374","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Charlson Comorbidity Index Derived from Chart Review","conceptCode":"C106374","definition":"A method of predicting mortality by weighting comorbid conditions calculated by reviewing an individual's chart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE7DE01D-2532-E657-E040-BB89AD4356E9","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3775783","version":"1","preferredName":"Solid Neoplasm","preferredDefinition":"Cancer of body tissues other than blood, bone marrow, or the lymphatic system.","longName":"C9292","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE81E3E8-A1C3-2ADC-E040-BB89AD4329FE","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCI:Charlson Comorbidity Index, Charlson, ME, 1987","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE81E3E8-A1D4-2ADC-E040-BB89AD4329FE","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for RTOG per request by V.Patel. mc 6/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3776031","version":"1","preferredName":"Metastatic Neoplasm Name","preferredDefinition":"A tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site.  Metastasis is characteristic of advanced malignancies, but in rare instances can be seen in neoplasms lacking malignant morphology. -- 2004_The words or language units by which a thing is known.","longName":"3776031v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3776030","version":"1","preferredName":"Metastatic Neoplasm Name","preferredDefinition":"A tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site.  Metastasis is characteristic of advanced malignancies, but in rare instances can be seen in neoplasms lacking malignant morphology. -- 2004:The words or language units by which a thing is known.","longName":"C3261:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Neoplasm","conceptCode":"C3261","definition":"A tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site.  Metastasis is characteristic of advanced malignancies, but in rare instances can be seen in neoplasms lacking malignant morphology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE833B93-BA14-4010-E040-BB89AD437C42","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCI:Charlson Comorbidity Index, Charlson, ME, 1987","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE833B93-BA25-4010-E040-BB89AD437C42","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"COOPERM","dateModified":"2013-06-07","changeDescription":"Created for RTOG per request by V.Patel. mc 6/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3775608","version":"1","longName":"CCI (Charlson Comorbidity Index)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3775609","version":"1","longName":"CCI","context":"NCIP"}]},{"publicId":"3835419","version":"1","longName":"Pharmacovigilance-Gabapentin/Pregabalin","context":"DCI","ClassificationSchemeItems":[{"publicId":"3835421","version":"1","longName":"Baseline","context":"DCI"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104935","version":"1","longName":"RTOG-1221","context":"NRG"}]}],"AlternateNames":[{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"CCI_ SOLIDTUMOR_NM","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Solid tumor (which?)","type":"Preferred Question Text","description":"Solid tumor (which?)","url":null,"context":"NCIP"}],"origin":"CCI:Charlson Comorbidity Index, Charlson, ME, 1987","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE833B93-BA42-4010-E040-BB89AD437C42","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"FORMBUILDER","dateModified":"2014-07-25","changeDescription":"Created for RTOG per request by V.Patel. mc 6/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}